PDS Biotechnology - 53 Year Dividend History | PDSB
Historical dividend payout and yield for PDS Biotechnology (PDSB) since 1971. The current TTM dividend payout for PDS Biotechnology (PDSB) as of December 20, 2024 is $0.00. The current dividend yield for PDS Biotechnology as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.069B |
$0.000B |
|
PDS Biotechnology Corp. is an immuno-oncology company. It is focused on developing a pipeline of clinical-stage immunotherapies to treat cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, cancer and other cancers. The company's products are based on the proprietary Versamune(R) platform technology, which activates and directs the human immune system. PDS Biotechnology Corp, formerly known as Edge Therapeutics Inc., is based in Berkeley Heights, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
